Breaking News

You are here » Indian-Commodity  :  Commodities  :  Govt Thinking Of Buffer Stock Of Main Elements

06-May2011

Govt Thinking Of Buffer Stock Of Main Elements

The govt is preparing to make a load stock of main farm nutrition viz; muriate of potash and urea to make sure good availability of fertilizers for the duration of the high period. The Department of Fertilizers is planning a Cabinet idea to manage buffer stock of 10 per cent of the all need of DAP and MoP and 5 % of the overall need of urea.

Prior also the division utilized to manage a buffer stock till 2010, though it was just 5 % of the nation`s need for DAp, urea and MoP.

However, Urea output in the area has intersected its goal in March this season by 0.62 lakh lots, making sure sufficient availability of the fertilizer to states. Approximated manufacture of urea at the time of March, 2011 was 18.25 lakh lots, against the goal of 17.63 lakh lots, an improve by 0.62 lakh tones.

Related News

View all news

BT Cotton Seeds Businesses Targeting Earnings Of Rs 700 Crore This Season

BT Cotton seeds organizations are targeting earnings of Rs 700 cr this season as a result of a rise ......

Gold Challenges To Maintain Earlier Increases As The Problems In Europe Prolongs

Gold prices surrounded reduce on Monday because the euro solved their deficits in opposition to the ......

Copper Seems To Lengthen Uptrend As Dollar Recoils

Copper rates were able to lengthen the uptrend for 3rd instantly period on Monday, as traders proved......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......